New MGA Paper Estimates Biosimilar Savings Opportunities for Large Employers

New MGA Paper Estimates Biosimilar Savings Opportunities for Large Employers

This paper estimates the savings opportunity from biosimilars in the medical benefit of a large employer-sponsored health plan, using real-world claims data. This analysis illustrates the savings potential of biosimilars in the commercial market and highlights the important role of employer-sponsored plans in promoting biosimilar utilization.